发明名称 ACTIVATION OF GROWTH FACTORS BY MATRIX VESICLES
摘要 A latent growth factor such as transforming growth factor beta (TGF beta ) is converted to active form by matrix vesicles or an extract from matrix vesicles. The matrix vesicles may be stimulated with a Regulator of Enhancing Factor (REF) such as 1,25-dihydroxy vitamin D (1,25-(OH)2D3) or steroid hormones which may be intercalated into the vesicle membrane. The latent growth factor may be activated in culturing cells such as chondrocytes that have been pretreated with 24,25-(OH)2D3 to activate cell differentiation, or in healing of bone or cartilage defects, and activation can be carried out in vivo or in vitro. Biodegradable polymeric implants may be prepared containing latent growth factor, REF, matrix vesicle or matrix vesicle extract.
申请公布号 EP0771193(A1) 申请公布日期 1997.05.07
申请号 EP19950920559 申请日期 1995.05.19
申请人 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 发明人 BOYAN, BARBARA, D.;SCHWARTZ, ZVI;BONEWALD, LYNDA, F.
分类号 A61L27/00;A61F2/28;A61K31/00;A61K31/557;A61K31/565;A61K31/59;A61K35/32;A61K38/18;A61K38/27;A61L27/54;A61L31/16;A61P43/00;C07K14/495;C12N5/077;(IPC1-7):A61K31/00;C12N5/08 主分类号 A61L27/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利